Analysts expect over 2021 rising revenue Amgen

Amgen will announce it's last quarter's results tomorrow. Over the current book year the total revenue from the company in Thousand Oaks will be 26.05 billion USD (consensus estimates). This is slightly more than 2021's revenue of 25.42 billion USD.

Historical revenues and results Amgen plus estimates 2021

The analysts expect for 2021 a net profit of 9.39 billion USD. For this year the consensus of the result per share is a profit of 16.39 USD. With this the price/earnings-ratio is 14.74.

Per share the analysts expect a dividend of 6.93 USD per share. Thus the dividend yield equals 2.87 percent. The average dividend yield of the biotech companies is a relatively high 2.28 percent.

Based on the current number of shares Amgen 's market capitalization equals 142.85 billion USD. 2

Historical stock prices Amgen

On Friday the stock closed at 241.54 USD.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.